Biohaven Pharmaceutical Holding Co Ltd.

RHUMBLINE ADVISERS

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/10/2022

Shares

94,287

Value ($000)

14,253

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/10/2022	14,253	0.0%	94,287	9/30/2022
2022 Q2	8/11/2022	11,581	0.0%	79,483	6/30/2022
2022 Q1	5/12/2022	7,407	0.0%	62,468	3/31/2022
2021 Q4	2/10/2022	8,794	0.0%	63,812	12/31/2021
2021 Q3	11/12/2021	8,912	0.0%	64,159	9/30/2021
2021 Q2	8/5/2021	5,994	0.0%	61,738	6/30/2021
2021 Q1	5/6/2021	3,546	0.0%	51,877	3/31/2021
2020 Q4	2/10/2021	5,037	0.0%	58,767	12/31/2020
2020 Q3	11/12/2020	3,678	0.0%	56,578	9/30/2020
2020 Q2	8/13/2020	5,113	0.0%	69,942	6/30/2020
2020 Q1	5/6/2020	1,897	0.0%	55,735	3/31/2020
2019 Q4	2/5/2020	2,791	0.0%	51,268	12/31/2019